NCT04090229 · Interventional trial
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis
Overall registry status Completed
Phase 1
Conditions Atopic Dermatitis
Delaware Valley sites
- Paddington Testing Co, INC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory